The OECD SPHeP-NCDs model is an advanced systems modelling tool for public health policy and strategic planning. It is used to predict the health and economic outcomes of the population of a country or a region up to 2050. The model consolidates previous OECD modelling work into a single platform to produce a comprehensive set of key behavioural and physiological risk factors, including obesity and physical activity, and their associated NCDs and other medical conditions. The model covers 52 countries, including OECD member countries, G20 countries, EU27 countries and OECD accession countries. For the purpose of this project, the model only covered OECD and non-OECD EU countries.
For each of the 52 countries, the model uses demographic and risk factor characteristics by age‑ and sex-specific population groups from international databases (see Figure A A.1). These inputs are used to generate synthetic populations, in which each individual is assigned demographic characteristics and a risk factor profile. Based on these characteristics, an individual has a certain risk of developing a disease each year. Individuals can develop 12 categories of disease, including seven directly related with alcohol (i.e. alcohol dependence, cirrhosis, injuries, cancer, depression, diabetes and CVDs). Therefore, the model takes into account the fact that individuals who do not develop an alcohol-related disease may develop other diseases that affect health care expenditure, workforce productivity and mortality. Incidence and prevalence of diseases in a specific country’s population were calibrated to match estimates from international datasets (IHME, 2017[2]; IARC, 2020[3]).
The links between risk factors and diseases are modelled through age‑ and sex-specific relative risks retrieved from the literature.
For each year, a cross-sectional representation of the population can be obtained, to calculate health status indicators such as life expectancy, disease prevalence and disability-adjusted life years using disability weights. Health care costs of disease treatment are estimated based on a per-case annual cost, which is extrapolated from national health-related expenditure data. The additional cost of multimorbidity is also calculated and applied. The extra cost of end-of-life care is also taken into account. In the model, people not dying from an alcohol-related disease or injury continue to consume medical care for other conditions (e.g. diabetes) and incur medical costs.
The labour market module uses relative risks to relate disease status to the risk of absenteeism, presenteeism (where sick individuals, even if physically present at work, are not fully productive), early retirement and employment. These changes in employment and productivity are estimated in number of full-time equivalent workers and costed based on a human capital approach, using national average wages.
There are two noteworthy limitations associated with using OECD’s SPHeP-NCD microsimulation model. First, microsimulation models, such as the one used in this study, are a simplified version of the population they aim to model given they are heavily constrained by data availability. Second, the model does not take into account the interconnecting relationship between different risk factors due to a lack of robust available evidence as well as the effect interventions have on risk factors other than those they directly aim to modify (e.g. an increase in physical activity may reduce pollution due to reduced use of private transport and thus the associated health issues). Due to the second limitation, it is likely the model underestimates the impact an intervention has on disease prevalence.